Strategic Expansion Allergan (Actavis) has a broad global footprint with revenue exceeding $10B and a sizable employee base, indicating ongoing capacity for new contract manufacturing, contract research, or outsourcing partnerships across its pharmaceutical and eye care divisions.

Aesthetics Growth Recent and ongoing emphasis on aesthetic products such as Latisse and the Future of Aesthetics Global Trends Report signals strong demand in cosmetic dermatology and medical aesthetics, presenting opportunities for suppliers of specialized packaging, devices, or digital marketing tech.

Tech Enablement Active tech stack including AWS, Azure, analytics, and user experience tools suggests openness to modernizing supply chain, ERP, CRM, and data analytics partnerships that improve manufacturing efficiency, forecasting, and customer engagement.

Regulatory and Recall Awareness Historical regulatory actions and recalls underscore a need for robust quality management, serialization, and compliance solutions, offering potential sales in quality control software, traceability, and risk management services.

Strategic Legal and IP Leverage Notable past litigation and ITC activity in partnerships indicate a potential for services around IP due diligence, contract lifecycle management, and dispute analytics to support collaborations and licensing arrangements.